Oncology Nutrition Market Report 2026

The oncology nutrition market size has grown strongly in recent years. It will grow from $2.08 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing awareness about nutrition in cancer care, growing prevalence of cancer types such as breast, blood, and gastrointestinal cancers, rising hospital and homecare adoption of enteral and parenteral nutrition, development of specialized oncology nutrition formulas, expansion of specialty clinics for cancer care.

The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for personalized oncology nutrition plans, increasing adoption of technology-enabled nutrition tracking, growth in homecare and outpatient nutrition services, rising focus on improving patient outcomes through nutrition, expansion of oncology nutrition services in emerging markets. Major trends in the forecast period include rising adoption of digital health platforms for oncology nutrition tracking, increasing integration of ai in personalized cancer diet planning, growing use of genomics and precision medicine in nutritional interventions, rising automation in hospital and homecare nutrition services, increasing iot-enabled monitoring of nutritional supply and patient compliance.

The rising prevalence of cancer is expected to drive the growth of the oncology nutrition market in the coming years. Cancer incidence refers to the number of new cancer cases occurring within a specific population over a defined period. Individuals diagnosed with cancer require adequate nutrition to support their overall health and treatment. Consequently, the increasing incidence of cancer is boosting demand for oncology-focused nutritional solutions. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050 over 35 million new cancer cases would occur worldwide, representing a 77% increase compared to an estimated 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the oncology nutrition market.

Key companies in the oncology nutrition market are focusing on developing innovative solutions, such as specialized nutrition programs for cancer patients, to improve treatment outcomes, support immune function, manage therapy-related side effects, and enhance overall quality of life during and after cancer treatment. Nutrition for cancer patients involves customized dietary plans and interventions tailored to the specific needs of individuals undergoing cancer therapy. For instance, in June 2024, AEACAP, a Spain-based patient support association, launched a nutrition series aimed at supporting cancer patients and their caregivers. This initiative includes a collection of videos released biweekly, presented by a specialized nutritionist, providing essential guidance on diet and nutrition during and after cancer treatment and emphasizing the critical role of proper nutrition in improving treatment outcomes and patient well-being.

In January 2024, Danone S.A., a France-based food company, partnered with National Resilience, Inc. to enhance nutritional care for cancer patients. The collaboration integrates a specialized nutrition support module into Resilience's digital oncology platform, aiming to address cancer-related malnutrition and improve patient outcomes and quality of life during treatment. National Resilience, Inc. is a US-based manufacturing and technology company focused on expanding access to complex medicines.

Major companies operating in the oncology nutrition market are B. Braun Melsungen AG, Abbott Laboratories, Abbott Nutrition, Nestle S.A., Nutricia, Baxter International Inc., Fresenius Kabi AG, Fresenius Kabi USA LLC, Global Health Products Inc., Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Primus Pharmaceuticals Inc., Solace Nutrition, Unimed Pharma LLC, Vitaflo USA LLC, Danone S.A., Ajinomoto Co Ltd, Otsuka Pharmaceutical Co Ltd, Grifols S.A., Victus Inc, Esperer Nutrition.

North America was the largest region in the oncology nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the oncology nutrition market by increasing import costs of nutritional products, supplements, and medical nutrition equipment, affecting hospitals, homecare providers, and specialty clinics mainly in north america, europe, and asia-pacific. While tariffs can raise operational expenses, they also encourage local production, sourcing diversification, and investment in domestic nutritional product manufacturing, thereby strengthening supply chains and reducing dependency on imports.

The oncology nutrition market research report is one of a series of new reports that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with a oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oncology nutrition refers to a healthy and balanced diet specifically prescribed for cancer patients. Consuming the right foods before, during, and after treatment can help patients feel better and maintain strength. Oncology nutrition is aimed at improving clinical outcomes for certain types of cancer.

The main cancer types addressed in oncology nutrition include blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers are cancers that develop in any part of the stomach or digestive tract. Nutrition approaches include enteral nutrition and parenteral nutrition, and these are provided in hospitals, homecare settings, specialty clinics, and other healthcare facilities.

The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.